Marshall E Kadin

Marshall E Kadin

UNVERIFIED PROFILE

Are you Marshall E Kadin?   Register this Author

Register author
Marshall E Kadin

Marshall E Kadin

Publications by authors named "Marshall E Kadin"

Are you Marshall E Kadin?   Register this Author

93Publications

1639Reads

16Profile Views

Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?

Plast Reconstr Surg 2020 Jan;145(1):30e-38e

Providence, R.I.; Dallas, Texas; New York, N.Y.; and Rome, Italy From the Department of Dermatology, Boston University School of Medicine and Roger Williams Medical Center; the Department of Plastic Surgery, University of Texas Southwestern Medical School; the Department of Pathology and Laboratory Medicine, Weill Cornell College of Medicine; and the Department of Clinical and Molecular Medicine, Sapienza University, Pathology Unit, Sant'Andrea Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0000000000006390DOI Listing
January 2020

Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

Am J Pathol 2020 Jan 11;190(1):2-10. Epub 2019 Oct 11.

Department of Dermatology, Roger Williams Medical Center, Providence, Rhode Island; Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029440193075
Publisher Site
http://dx.doi.org/10.1016/j.ajpath.2019.09.005DOI Listing
January 2020

A histo-immunopathologic and prognostic study of erythrodermic cutaneous T-cell lymphoma.

J Cutan Pathol 2019 Dec 4;46(12):913-924. Epub 2019 Sep 4.

Department of Dermatology, Boston University and Roger Williams Medical Center, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.13564DOI Listing
December 2019

Prevalence of atopy and staphylococcal superantigen-specific immunoglobulin E (IgE) antibodies and total serum IgE in primary cutaneous T- and B-cell lymphoma.

J Dermatol 2019 Dec 6;46(12):1170-1178. Epub 2019 Oct 6.

Department of Dermatology, Boston University and Roger Williams Medical Center, Providence, Rhode Island, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1346-8138.15059DOI Listing
December 2019

Commentary on: A Case Report of a Breast Implant-Associated Plasmacytoma and Literature Review of Non-ALCL Breast Implant-Associated Neoplasms.

Authors:
Marshall E Kadin

Aesthet Surg J 2019 Jun;39(7):NP240-NP242

Boston University and Roger Williams Medical Center, and Research Scientist, Department of Pathology and Laboratory Medicine, Rhode Island Hospital, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/asj/sjz049DOI Listing
June 2019

Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Aesthet Surg J 2019 Feb 21. Epub 2019 Feb 21.

Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/asj/sjy327DOI Listing
February 2019

What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

Authors:
Marshall E Kadin

Aesthet Surg J 2019 Jan;39(Supplement_1):S28-S35

Professor of Dermatology, Boston University School of Medicine and Roger Williams Medical Center, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/asj/sjy250DOI Listing
January 2019

SATB1 Defines a Subtype of Cutaneous CD30 Lymphoproliferative Disorders Associated with a T-Helper 17 Cytokine Profile.

J Invest Dermatol 2018 08 3;138(8):1795-1804. Epub 2018 Mar 3.

Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X183020
Publisher Site
http://dx.doi.org/10.1016/j.jid.2018.02.028DOI Listing
August 2018

Dual Role of EZH2 in Cutaneous Anaplastic Large Cell Lymphoma: Promoting Tumor Cell Survival and Regulating Tumor Microenvironment.

J Invest Dermatol 2018 05 15;138(5):1126-1136. Epub 2017 Dec 15.

Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China; Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.10.036DOI Listing
May 2018

Commentary on: Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman.

Aesthet Surg J 2017 09;37(8):NP88-NP89

Boston University School of Medicine, Boston, MA; Roger Williams Medical Center, Providence, RI. Jersey Shore University Medical Center, Neptune, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/asj/sjx105DOI Listing
September 2017

Primary cutaneous anaplastic large cell lymphoma with intralymphatic involvement associated with chronic lymphedema.

J Cutan Pathol 2017 Jul 5;44(7):616-619. Epub 2017 May 5.

Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12933DOI Listing
July 2017

CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Aesthet Surg J 2017 07;37(7):771-775

Jersey Shore University Medical Center, Neptune, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/asj/sjw286DOI Listing
July 2017

Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas.

Oncoimmunology 2017 10;6(3):e1273310. Epub 2017 Feb 10.

Department of Dermatology and Allergology, University of Helsinki and Helsinki University Central Hospital , Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1273310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384345PMC
February 2017

CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells.

Am J Pathol 2017 Jan 19;187(1):163-175. Epub 2016 Nov 19.

Department of Hematology, School of Medicine, Kitasato University, Minami-ku, Sagamihara, Kanagawa, Japan; Division of Hematology, Department of Laboratory Sciences, School of Allied Health Sciences, Kitasato University, Minami-ku, Sagamihara, Kanagawa, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2016.09.007DOI Listing
January 2017

Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.

Aesthet Surg J 2016 Jul 15;36(7):773-81. Epub 2016 Mar 15.

Dr Kadin is a Professor of Dermatology, Boston University School of Medicine, Boston, MA; and a Staff Physician, Roger Williams Medical Center, Providence, RI. Dr Deva is an Associate Professor of Cosmetic, Plastic, and Reconstructive Surgery, Macquarie University, NSW, Australia. Ms Xu is a Research Assistant, Dr Morgan is Director of the Research Core Facility, and Dr Khare is Director of the Cancer Immunotherapy and Gene Therapy Facility, Roger Williams Medical Center, Providence, RI. Dr MacLeod is Director of Cytogenetics at the Leibniz Institute, DSMZ - German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany. Dr Van Natta is an Associate Clinical Professor, Department of Surgery, Indiana University School of Medicine, Indianapolis, IN. Dr Adams is an Associate Clinical Professor, Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX. Dr Brody is Professor Emeritus in the Division of Plastic Surgery, and Dr Epstein is a Professor of Pathology, University of Southern California Keck School of Medicine, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/asj/sjw023DOI Listing
July 2016

Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma.

Plast Reconstr Surg 2016 Jun;137(6):1659-69

Boston, Mass.; Los Angeles, Calif.; Houston, Texas; Indianapolis, Ind.; Sydney, New South Wales, and Melbourne, Victoria, Australia; and Riyadh and Qassim, Kingdom of Saudi Arabia From the Boston University School of Medicine and Roger Williams Medical Center; the University of Southern California; the University of Texas M. D. Anderson Cancer Center; Meridian Plastic Surgery; the Surgical Infection Research Group, Macquarie University, Peter MacCallum Cancer Center, University of Melbourne, and the Department of Allergy and Immunology, Children's Hospital at Westmead; the Division of Microbiology, Prince Sultan Military Medical City, and the Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0000000000002010DOI Listing
June 2016

Commentary about papular mycosis fungoides, lymphomatoid papulosis and lymphomatoid pityriasis lichenoides: more similarities than differences.

J Cutan Pathol 2016 Apr 22;43(4):303-12. Epub 2015 Dec 22.

Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, RI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cup.12653DOI Listing
April 2016

Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines.

Br J Haematol 2015 Sep 24;170(6):837-46. Epub 2015 Jun 24.

Department of Haematology, School of Medicine, Kitasato University, Kanagawa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13508DOI Listing
September 2015

CD30(+) cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes.

J Am Acad Dermatol 2015 Mar 10;72(3):508-15. Epub 2015 Jan 10.

Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts; Roger Williams Medical Center, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.11.021DOI Listing
March 2015

IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis.

J Invest Dermatol 2014 Nov 21;134(11):2757-2767. Epub 2014 Jul 21.

Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany; Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany; Research Center Immunosciences, University Hospital Charité, Berlin, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2014.308DOI Listing
November 2014

Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.

Clin Cancer Res 2014 Nov 11;20(21):5507-16. Epub 2014 Sep 11.

Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany. Research Center Immunosciences, University Hospital Charité, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0707DOI Listing
November 2014

Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):1-14

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (LMM, JNS, SMM, JSC, SIB, MSL); Department of Health Sciences Research, College of Medicine, Mayo Clinic, Rochester, MN (JRC, DR, ADN, SLS); Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, Australia, The Australian School of Advanced Medicine, Macquarie University, Sydney, Australia (JJT); Prince of Wales Clinical School, University of New South Wales, Sydney, Australia (CMV); Department of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, CA (SSW); Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden (KES); Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Institut Catala d'Oncologia, IDIBELL, Barcelona, Spain, CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain (SdS, YB); Inserm, Centre for Research in Epidemiology and Population Health (CESP), Environmental Epidemiology of Cancer Group and Univ Paris Sud, Villejuif, France (AM, JC); Registry of Hematological Malignancies in Gironde, Bergonié Institute, Bordeaux, France (AM); Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA (PMB); Department of Health Studies, University of Chicago, Chicago, IL (BCHC); Department of Epidemiology, Comprehensive Cancer Center, University of Alabama, Birmingham, AL (CFS); Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT (YZ); Information Management Systems, Inc, Silver Spring, MD (MS); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, UK (EVK, ER); Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada (JJS); School of Medicine and Dentistry, University of Rochester, Rochester, NY (JLK); Department of Epidemiology, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri and Department of Clinical Sciences and Community Hea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155460PMC
August 2014

Medical history, lifestyle, family history, and occupational risk factors for peripheral T-cell lymphomas: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):66-75

Department of Cancer Etiology, Beckman Research Institute of the City of Hope, Duarte, CA (SSW); Winship Cancer Institute, Emory University, Atlanta, GA (CRF); Department of Dermatology, Boston University, Boston, MA, Roger Williams Medical Center, Providence, RI (MEK); Health Sciences Practice, Exponent, Inc., Menlo Park, CA, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA (ETC); National Centre for Epidemiology and Population Health, The Australian National University, Canberra, Australia (AMH); Department of Health Sciences Research, Mayo Clinic, Rochester, MN (SMA); Department of Laboratory Medicine and Pathology, Mayo Clinic Cancer Center, Rochester, MN (ALF); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK (TL); Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY (PB); Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark (MM); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (QL, JNS, LMM); Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT (YZ); Department of Pathology, City of Hope National Medical Center, Duarte, CA (DDW).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155466PMC
August 2014

Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):98-105

Department of Health Studies, University of Chicago, Chicago, IL (BA-K); Department of Public Health, Clinical and Molecular Medicine, Occupational Health Section, University of Cagliari, Cagliari, Italy (PC); Dipartimento di Epidimologia, IRCCS- Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy, Community Health, University of Milan, Milan, Italy (CLV); Health Sciences Practice, Exponent, Inc., Menlo Park, CA, Department of Health Research and Policy, Stanford University, Stanford, CA (ETC); Prince of Wales Clinical School, University of New South Wales, Sydney, Australia (CMV); Department of Dermatology, Boston University, Boston, MA, Roger Williams Medical Center, Providence, RI (MEK); Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada (JJS); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health Bethesda, MD (LMM, JNS); Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK (EVK); Biostatistics Center, Massachusetts General Hospital, Boston, MA (CK); Department of Laboratory Medicine and Pathology, Mayo Clinic Cancer Center, Rochester, MN (ALF); Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, CA (SSW); Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT (YZ).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155463PMC
August 2014

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

J Natl Cancer Inst Monogr 2014 Aug;2014(48):130-44

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (LMM, SMM, JSC, PH, NR, AB, KPC, QL, SIB, MSL, JNS); Department of Health Sciences Research (SLS, JRC, TMH), Division of Hematology (TGC), and Divison of General Internal Medicine (ML), College of Medicine, Mayo Clinic, Rochester, MN; Department of Cancer Etiology, City of Hope Beckman Research Institute, Duarte, CA (SSW, LB, AL); Prince of Wales Clinical School, University of New South Wales, Sydney, Australia (CMV); Department of Epidemiology, Comprehensive Cancer Center, University of Alabama, Birmingham, AL (CFS); Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, San Francisco, CA (PMB, EAH); Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, Institut Català d' Oncologia, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain, CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain (SdS, YB); Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden (KES); Department of Health Studies, University of Chicago, Chicago, IL (BCHC); Department of Environmental Health Sciences (YZ, TZ) and Department of Biostatistics (TRH), Yale School of Public Health, New Haven, CT; INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Environmental Epidemiology of Cancer Group, Villejuif, France, Univ Paris Sud, UMRS 1018, Villejuif, France (AM, JC, LO); Registry of Hematological Malignancies in Gironde, Bergonié Institute, 33076 Bordeaux, France (AM); Department of Histopathology, Douglass Hanly Moir Pathology, Macquarie Park, Australia, The Australian School of Advanced Medicine, Macquarie University, Sydney, Australia (JJT); Department of Medical Epidemiology and Biostatistics (H-OA) and Department of Oncology and Pathology (BG), Karolinska Institutet, Stockholm, Swed

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncimonographs/lgu013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155467PMC
August 2014

Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium.

J Am Acad Dermatol 2014 Feb;70(2):374-6

Department of Dermatology, University of Wisconsin School of Medicine, Madison, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.09.007DOI Listing
February 2014

Prognostic factors and risk stratification in early mycosis fungoides.

Leuk Lymphoma 2014 Jan 7;55(1):44-50. Epub 2013 May 7.

Department of Oncology and The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutes , Baltimore, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.790541DOI Listing
January 2014

High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides.

J Invest Dermatol 2012 Mar 10;132(3 Pt 1):703-10. Epub 2011 Nov 10.

Department of Dermatology, Boston University, Roger Williams Medical Center, Providence, Rhode Island 02908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2011.351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278552PMC
March 2012

Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma.

Am J Pathol 2012 Feb 19;180(2):831-8. Epub 2011 Nov 19.

Department of Hematology, School of Medicine, Kitasato University, Kanagawa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2011.10.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429177PMC
February 2012

Lymphomatoid papulosis followed by pityriasis lichenoides: a common pathogenesis?

Am J Dermatopathol 2011 Dec;33(8):835-40

Department of Dermatology, Johns Hopkins Medical Institutes, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0b013e3181f4d8c3DOI Listing
December 2011

Hodgkin's lymphoma therapy: past, present, and future.

Expert Opin Pharmacother 2010 Dec;11(17):2891-906

Department of Medicine, Roger Williams Medical Center, Providence Rhode Island 02908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2010.515979DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978071PMC
December 2010

Macrophages in Hodgkin's lymphoma.

Authors:
Marshall E Kadin

N Engl J Med 2010 Jun;362(22):2135-6; author reply 2136

View Article

Download full-text PDF

Source
June 2010

Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP.

J Invest Dermatol 2010 Mar 5;130(3):826-40. Epub 2009 Nov 5.

Department of Dermatology and Allergy, Charité-University Medical Center Berlin, HTCC-Skin Cancer Center, Berlin, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0022202X1534726
Publisher Site
http://dx.doi.org/10.1038/jid.2009.299DOI Listing
March 2010

Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma.

Appl Immunohistochem Mol Morphol 2010 Jan;18(1):16-23

Departments of Pathology, Beth Israel Deaconess Medical center, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e3181a307f7DOI Listing
January 2010

Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.

Authors:
Marshall E Kadin

Oncology (Williston Park) 2009 Nov;23(13):1158-64

Department of Dermatology and Skin Surgery, Boston University School of Medicine and Roger Williams Medical Center, Providence, Rhode Island 02908, USA.

View Article

Download full-text PDF

Source
November 2009

Teenager with hairy cell leukemia: 30-year follow-up.

J Clin Oncol 2009 Jan 1;27(1):155-6. Epub 2008 Dec 1.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.20.3372DOI Listing
January 2009

Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma.

Hum Pathol 2008 Jun 30;39(6):910-6. Epub 2008 Jan 30.

Department of Pathology, New England Medical Center, Boston, MA 02111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2007.10.021DOI Listing
June 2008

Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma.

Lab Invest 2008 Jan 29;88(1):48-57. Epub 2007 Oct 29.

Department of Hematology, School of Medicine, Kitasato University, Sagamihara, Kanagawa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.3700696DOI Listing
January 2008

The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling.

Blood 2007 Nov 9;110(9):3374-83. Epub 2007 Aug 9.

Klinische Abteilung für Hämatologie, Universitätsklinik für Innere Medizin, Medizinische, Universität Graz, Auenbruggerplatz 38, A-8036 Graz, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-02-071258DOI Listing
November 2007

Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.

Cancer Control 2007 Apr;14(2):124-32

Hematopathology and Laboratory Medicine Program, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327480701400205DOI Listing
April 2007

Pathobiology of CD30+ cutaneous T-cell lymphomas.

Authors:
Marshall E Kadin

J Cutan Pathol 2006 Feb;33 Suppl 1:10-7

Laboratory Medicine, Yamins 309, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0303-6987.2006.00507.xDOI Listing
February 2006

Apoptosis in CD30-positive lymphoproliferative disorders of the skin.

Exp Dermatol 2005 May;14(5):380-5

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0906-6705.2005.00293.xDOI Listing
May 2005

Polymorphism of the CD30 promoter microsatellite repressive element is associated with development of primary cutaneous lymphoproliferative disorders.

Cancer Epidemiol Biomarkers Prev 2005 May;14(5):1322-5

The Western Australian Institute for Medical Research and Centre for Medical Research, The University of Western Australia, Level 6, MRF Building, 50 Rear Murray Street, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-04-0826DOI Listing
May 2005

Aggressive cutaneous T-cell lymphomas after TNFalpha blockade.

J Am Acad Dermatol 2004 Oct;51(4):660-2

Department of Dermatology at Harvard Medical School, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2004.03.047DOI Listing
October 2004

Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma.

Exp Dermatol 2004 Aug;13(8):472-83

Department of Dermatology, UniversitätsSpital Zürich, Zürich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0906-6705.2004.00176.xDOI Listing
August 2004

Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor.

Cancer Detect Prev 2004 ;28(1):57-64

Department of Pediatrics, Program in Cell Biology, National Jewish Medical and Research Center, Goodman Building, K1011, 1400 Jackson Street, Denver, CO 80206, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0361090X0300203
Publisher Site
http://dx.doi.org/10.1016/j.cdp.2003.11.001DOI Listing
July 2004

The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma.

Cancer Cell 2004 Apr;5(4):353-64

Fourth Department of Internal Medicine, Faculty of Medicine, Kitasato University, 1-15-1 Kitasato, Sagamihara, Kanagawa 228-8555, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1535-6108(04)00084-4DOI Listing
April 2004

Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases.

Arch Dermatol 2004 Mar;140(3):306-12

Department of Dermatology, the Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass. 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archderm.140.3.306DOI Listing
March 2004

Improved sensitivity of T-cell clonality detection in mycosis fungoides by hand microdissection and heteroduplex analysis.

Arch Dermatol 2003 Dec;139(12):1571-5

Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archderm.139.12.1571DOI Listing
December 2003

Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy.

J Clin Oncol 2003 Sep;21(18):3526-34

Department of Lymphoma and Myeloma, Unit 429, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.09.037DOI Listing
September 2003

Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand.

Clin Cancer Res 2003 Jul;9(7):2744-54

Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
July 2003

Systemic and primary cutaneous anaplastic large cell lymphomas.

Semin Hematol 2003 Jul;40(3):244-56

Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0037-1963(03)00138-0DOI Listing
July 2003

Proceedings of the Boston workshop on cytogenetics and molecular genetics of hematologic malignancies, November 8 to 11, 2001: introduction.

Authors:
Marshall E Kadin

Hum Pathol 2003 Apr;34(4):305

Course Director, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/hupa.2003.91DOI Listing
April 2003

Genetic and molecular genetic studies in the diagnosis of T-cell malignancies.

Authors:
Marshall E Kadin

Hum Pathol 2003 Apr;34(4):322-9

Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/hupa.2003.94DOI Listing
April 2003

Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin.

Carcinogenesis 2003 Feb;24(2):301-6

Department of Medicine, Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/24.2.301DOI Listing
February 2003

Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin.

J Invest Dermatol 2002 Jun;118(6):949-56

Department of Pathology, Beth Israel Deaconess Medical Center-Harvard Medical School, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0022202X1541673
Publisher Site
http://dx.doi.org/10.1046/j.1523-1747.2002.01794.xDOI Listing
June 2002

Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.

J Cutan Pathol 2002 May;29(5):295-300

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-0560.2002.290507.xDOI Listing
May 2002

Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.

Oncogene 2002 Apr;21(16):2493-503

Division of Pathology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1205337
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1205337DOI Listing
April 2002